| |
•
Table I. |
Cultivation of Papaver somniferum for the production of opium, 2019-2025
|
| |
•
Table II. |
Cultivation of Papaver somniferum for purposes other than the production of opium, 2019-2025: production of poppy straw (M, T, C, N and O)
|
| |
•
Table III. |
Extraction of alkaloids from opium, 2019-2023
|
| |
•
Table IV. |
Extraction of morphine from poppy straw (M),
2019-2023
|
| |
•
Table V. |
Extraction of thebaine from poppy straw (T and M),
2019-2023
|
| |
•
Table VI. |
Conversion of morphine,
2019-2023
|
| |
•
Table VII. |
Conversion of thebaine,
2019-2023
|
| |
•
Table VIII. |
Manufacture of alkaloids contained in concentrate of poppy straw,
2019-2023
|
| |
•
Table IX. |
Extraction of alkaloids from opium, 2019-2023
|
| |
•
Table X. |
Manufacture of the principal narcotic drugs, 2019-2023: |
| |
|
•
Derivatives of opium alkaloids |
| |
|
•
Synthetic opioids |
| |
•
Table XI. |
Production, utilization, imports and exports of coca leaf and manufacture of cocaine, 2019-2023
|
| |
•
Table XII. |
Consumption of the principal narcotic drugs and calculated consumption of buprenorphine, 2019-2023
|
| |
•
Table XIII. |
Consumption of other narcotic drugs, 2019-2023: |
| |
|
•
Fentanyl, principal fentanyl analogues and piritramide |
| |
|
•
Other derivatives of opium alkaloids |
| |
|
•
Other synthetic opioids |
| |
•
Table VIV. |
Levels of consumption of narcotic drugs, in defined daily doses for statistical purposes per million inhabitants per day, 2021-2023:
|